Bridging Therapy in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Receiving Standard of Care Brexucabtagene Autoleucel: Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA) Chenyu Lin , Stephanie B. Tsai , Gregory W. Roloff , Amy Zhang , Ibrahim Aldoss , Noam E. Kopmar , Simone E. Dekker , Nikeshan Jeyakumar , Vishal K. Gupta , Timothy E. O'Connor , Kaitlyn C. Dykes , Mohamed Ahmed , Bhagirathbhai Dholaria , Hector Zambrano , Danielle Bradshaw , Aaron C. Logan , Sean Tracy , Michal Kubiak , Melhem M. Solh , Santiago Mercadal , Marc Schwartz , Akash Mukherjee , Minoo Battiwalla , Paul Shaughnessy , Navneet Majhail , Luke Mountjoy , Shahbaz A. Malik , John Mathews , Abdullah Ladha , Anjali S. Advani , Maryann Stefan , Caitlin Guzowski , Rasmus T. Hoeg , Talal Hilal , Jozal Moore , Kristen M. O'Dwyer , Joshua Sasine , Catherine J. Lee , Vamsi K. Kota , Divya Koura , Muthu Veeraputhiran , Betsy Blunk , Jessica T. Leonard , Caspian H. Oliai , Veronika Bachanova , Wendy Stock , Vinod Pullarkat , Ryan D. Cassaday , Katharine Miller , Lori S. Muffly , Ahmed Galal , Bijal D. Shah , Rawan Faramand BLOOD（2023）
Key words
T Cell Therapy, Treatment Outcomes
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
